Concepedia
Clinical and Experimental Medicine · 2006 · 39 citations · 7 references
PharmacyPharmacotherapyPreventive MedicineRespiratory PharmacotherapyAcute Respiratory Distress SyndromeRespiratory DiseaseRespiratory Disease PreventionRespiratory MedicineAcute Upper Respiratory Tract InfectionsAmbroxol TherapyUpper Respiratory Infections
7
Surfactant apoprotein Mr = 26,000-36,000 enhances uptake of liposomes by type II cells.
Jo Rae Wright, R.E. Wager, Samuel Hawgood et al. · Journal of Biological Chemistry · 1987 · 304 citations · Full text
Life Sciences, Biochemistry, Cell Biology +9
Human Pulmonary Surfactant Protein (SP-A), a Protein Structurally Homologous to C1q, Can Enhance FcR- and CR1-mediated Phagocytosis
Andrea J. Tenner, Susan L. Robinson, J D Borchelt et al. · Journal of Biological Chemistry · 1989 · 293 citations · Full text
Life Sciences, Cell Biology, Immunology +14
Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels
Bing Yang, Dengfu Yao, M. Ohuchi et al. · European Respiratory Journal · 2002 · 82 citations · Full text
Medicine, Infectious Diseases, Pharmacology +17
Ambroxol inhibits the release of histamine, leukotrienes and cytokines from human leukocytes and mast cells
Bernhard F. Gibbs, W. Schmutzler, I. B. Vollrath et al. · Inflammation Research · 1999 · 74 citations
Life Sciences, Immunology, Pharmacology +14
Pulmonary surfactant is a potential endogenous inhibitor of proteolytic activation of Sendai virus and influenza A virus
Hiroshi Kido, Kentaro Sakai, Yasuo Kishino et al. · FEBS Letters · 1993 · 64 citations
Life Sciences, Infectious Diseases, Pathobiology +17